Invention Grant
- Patent Title: SSTR-targeted conjugates and particles and formulations thereof
-
Application No.: US16345306Application Date: 2017-10-27
-
Publication No.: US11213590B2Publication Date: 2022-01-04
- Inventor: Rajesh R. Shinde , Rossitza G. Alargova , Patrick Lim Soo , Beata Sweryda-Krawiec , Leila Alland , Christopher Sears
- Applicant: TARVEDA THERAPEUTICS, INC.
- Applicant Address: US MA Watertown
- Assignee: TARVEDA THERAPEUTICS, INC.
- Current Assignee: TARVEDA THERAPEUTICS, INC.
- Current Assignee Address: US MA Watertown
- Agency: DT Ward, PC
- Agent Donna T. Ward; Heng Zhu
- International Application: PCT/US2017/058701 WO 20171027
- International Announcement: WO2018/081521 WO 20180503
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K47/64 ; A61K31/537 ; A61K47/14 ; A61K47/26 ; A61K51/08 ; C07K14/72

Abstract:
Conjugates of an active agent such as DM1 attached to a targeting moiety, such as a somatostatin receptor binding moiety, via a linker, and particles comprising such conjugates have been designed. Such conjugates and particles can provide improved temporospatial delivery of the active agent, improved biodistribution and penetration in tumor, and/or decreased toxicity. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer.
Public/Granted literature
- US20190262460A1 SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF Public/Granted day:2019-08-29
Information query
IPC分类:
A | 人类生活必需 |
A61 | 医学或兽医学;卫生学 |
A61P | 化合物或药物制剂的特定治疗活性 |
A61P35/00 | 抗肿瘤药 |